在卵巢清细胞癌中,PPPP2R1A突变会导致ATR抑制剂敏感性
James Stewart1,2,3, Dragomir B Krastev1,2, Rachel Brough1,2
1The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, SW3 6JB, UK.
Oncogene
|February 12, 2025
概括
在卵巢清细胞癌 (OCCC) 中,非活性化蛋白酸酶2A (PP2A) 增加了对ATR抑制剂的敏感性,特别是在具有ARID1A突变的瘤中. PPP2R1A突变可能作为ATR抑制剂治疗的预测生物标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 在ARID1A和ATR通路之间的合成致死性为卵巢清细胞癌 (OCCC) 提供了治疗策略.
- ATR 抑制剂 (ATRi) 正在对OCCC进行研究,但需要对患者进行分层.
研究的目的:
- 为了确定使ARID1A突变OCCC对ATR抑制剂敏感的基因变异.
- 评估蛋白酸酶2A (PP2A) 在ATRi敏感性中的作用.
- 评估PPP2R1A突变作为OCCC中ATRi治疗的预测生物标志物.
主要方法:
- 采用CRISPR-Cas9突变和干扰选,以确定ATRi敏感性的遗传修饰剂.
- 对ARID1A和PPP2R1A突变的新OCCC患者队列的分析.
- 使用CRISPR主要编辑来创建PPP2R1A突变OCCC的同源模型.
- 在临床前模型中评估ATRi诱导的细胞应激,基因组不稳定性和敏感性.
主要成果:
- 包括PPP2R1A在内的PP2A子单元的非激活增加了ARID1A突变OCCC中的ATRi敏感性.
- 大约52%的OCCC患者患有瘤性PPP2R1A p.R183突变,其中一半也患有ARID1A突变.
- PPP2R1A p.R183 突变 (W 和 P 变体) 诱导ATRi介导的S阶段应激,线粒体进入缺陷和基因组不稳定性.
- 在ARID1A突变OCCC模型中,PPP2R1A p.R183突变增强了体外和体内ATRi敏感性.
结论:
- PP2A无活化,特别是PPP2R1A突变,使OCCC对ATR抑制剂产生敏感性.
- PPP2R1A p.R183突变在OCCC中普遍存在,并且与增强的ATRi敏感性有关.
- 应评估PPP2R1A突变状态作为预测OCCC患者ATRi反应的潜在生物标志物.
更多相关视频
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
6.6K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.2K
相关概念视频
01:20The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K